This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Allele-Specific Inactivation of an Autosomal Dominant Epidermolysis Bullosa Simplex Mutation Using CRISPR-Cas9.
The CRISPR journal · 2022 · senior author
Fibroblast growth factor-2 is a sputum remodeling biomarker of severe asthma.
The Journal of asthma : official journal of the Association for the Care of Asthma · 2014 · senior author
Asthma and rhinitis: what is the relationship?
Current opinion in allergy and clinical immunology · 2012
Latest funding
- $1,137,500
GMEB-SASS: The first clinical trial phase I/II using a genetically modified epidermolysis bullosa self-assembled skin substitute to treat dystrophic epidermolysis bullosa, a severe rare skin disease
CIHR · 2024 · Principal investigator
- $1,950,000
CIHR - Quebec Respiratory Health Training Program
CIHR · 2008 · Co-investigator
9 publications.
Allele-Specific Inactivation of an Autosomal Dominant Epidermolysis Bullosa Simplex Mutation Using CRISPR-Cas9.
Bchetnia M, Dionne Gagné R, Powell J, Morin C, McCuaig C, Dupérée A, Germain L, Tremblay JP, Laprise C
Fibroblast growth factor-2 is a sputum remodeling biomarker of severe asthma.
Bissonnette ÉY, Madore AM, Chakir J, Laviolette M, Boulet LP, Hamid Q, Bergeron C, Maghni K, Laprise C
Asthma and rhinitis: what is the relationship?
Boulay ME, Morin A, Laprise C, Boulet LP
Alveolar macrophages in allergic asthma: an expression signature characterized by heat shock protein pathways.
Madore AM, Perron S, Turmel V, Laviolette M, Bissonnette EY, Laprise C
Genetic variation in immune signaling genes differentially expressed in asthmatic lung tissues.
Tremblay K, Daley D, Chamberland A, Lemire M, Montpetit A, Laviolette M, Musk AW, James AL, Chan-Yeung M, Becker A, Kozyrskyj AL, Sandford AJ, Hudson TJ, Paré PD, Laprise C
Genes to diseases (G2D) computational method to identify asthma candidate genes.
Tremblay K, Lemire M, Potvin C, Tremblay A, Hunninghake GM, Raby BA, Hudson TJ, Perez-Iratxeta C, Andrade-Navarro MA, Laprise C
Replication of an association between 17q21 SNPs and asthma in a French-Canadian familial collection.
Madore AM, Tremblay K, Hudson TJ, Laprise C
Distribution of CFTR mutations in Saguenay-Lac-Saint-Jean: proposal of a panel of mutations for population screening
Madore A-M, Prevost C, Dorfman R, Taylor C, Durie P, Zielenski J, Laprise C
Clinical features and airway inflammation in mild asthma versus asymptomatic airway hyperresponsiveness.
Boulet LP, Prince P, Turcotte H, Lemière C, Olivenstein R, Laprise C, Larivée P, Bégin P, Laviolette M
GMEB-SASS: The first clinical trial phase I/II using a genetically modified epidermolysis bullosa self-assembled skin substitute to treat dystrophic epidermolysis bullosa, a severe rare skin disease
Principal investigators: Germain, Lucie; Pope, Elena; Caruso, Manuel P; Fradette, Julie; Guertin, Jason R; Laprise, Catherine; Laurin, Mélanie; Zawati, Ma'n Hilmi M.
Keywords: Collagen; Epidermolysis Bullosa; Gene Therapy; Novel Treatment; Pediatric Disease; Rare Disease; Skin Genetic Disease; Skin Grafting; Stem Cells, Skin; Tissue Engineering
CIHR - Quebec Respiratory Health Training Program
Principal investigators: Maltais, François; Berthiaume, Yves; Martin, James G; Rousseau, Eric C; Schwartzman, Kevin
Keywords: Knowledge Transfer; Respiratory Biology; Respiratory Epidemiology And Health; Student Exchange Programs; Transdisciplinary Training And Research
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Basic Sciences
- Ecole de psychologie
- Médecine
- Chirurgie
- Anesthesia
- Other
Co-authors at Université Laval, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.